Fate Therapeutics, Inc. (FATE)
2.25
+0.15
(+7.14%)
USD |
NASDAQ |
May 22, 16:00
2.24
-0.01
(-0.44%)
After-Hours: 20:00
Fate Therapeutics Profit Margin (Quarterly) : -2.40K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.36% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| Amgen, Inc. | 21.02% |
| Savara, Inc. | -- |
| Biogen, Inc. | 13.29% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -55.48% |
| Return on Assets | -37.81% |
| Return on Invested Capital | -41.39% |
| Gross Profit Margin (Quarterly) | -124.6% |
| Operating Margin (Quarterly) | -2.54K% |
| Return on Net Operating Assets | -126.2% |